A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients

Journal of Clinical Psychiatry

Volumn 66, Issue 2, 2005, Pages 248-252

  Iwasaki, Koh ^a   Satoh Nakagawa, Takuma ^b   Maruyama, Masahiro ^b   Monma, Yasutake ^c   Nemoto, Miyako ^b   Tomita, Naoki ^b   Tanji, Haruko ^b   Fujiwara, Hironori ^a   Seki, Takashi ^a   Fujii, Masahiko ^d   Arai, Hiroyuki ^a   Sasaki, Hidetada ^b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d National Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; NEUROLEPTIC AGENT; TIAPRIDE; UNCLASSIFIED DRUG; YOKUKAN SAN;

AGED; ARTICLE; BARTHEL INDEX; CHINESE MEDICINE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHIATRIC INVENTORY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SINGLE BLIND PROCEDURE;

EID: 20044382588     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0214     Document Type: Article

References (29)

1. Steele C, Rovner B, Chase GA, et al. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990;147:1049-1051
2. Norton LE, Malloy PF, Salloway S. The impact of behavioral symptoms on activities of daily living in patients with dementia. Am J Geriatr Psychiatry 2001;9:41-48
3. Rainer MK, Masching AJ, Ertl MG, et al. Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia. J Clin Psychiatry 2001;62:894-900
4. Paleacu D, Mazeh D, Mirecki I, et al. Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease. Clin Neuropharmacol 2002;25:313-317
5. Jeste DV, Caligiuri MP, Paulsen JS. Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 1995;52:756-765
6. Suzuki T, Arai H, Iwasaki K, et al. A Japanese herbal medicine (Kami-Untan-To) in the treatment of Alzheimer's disease: a pilot study. Alzheimers Rep 2001;4:177-182
7. Iwasaki K, Kobayashi S, Chimura Y, et al. A randomized, double-blind, placebo-controlled clinical trial of the Chinese herbal medicine "ba wei di huang wan" in the treatment of dementia. J Am Geriatr Soc 2004;52: 1518-1521
8. Tahara E, Shintani T, Moriyama K, et al. Two cases with positive symptoms by dementia of elderly successfully treated with Yokukan-san [in Japanese, abstract in English]. Kampo-no-Rinsho 2003;1:105-114
9. Tsunekawa S, Iguchi A. Effects of yi-gan san jia chenpi banxia on BPSD of the elderly [in Japanese]. Kampo-Medicine 2002;26:128-130
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington DC: American Psychiatric Association; 1994
11. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
12. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965;14:61-65
13. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:3208-3214
14. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260
15. McKieth IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 1999;53:902-905
16. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-676
17. Mega S, Mastermann DM, O'Connor S, et al. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer's disease. Arch Neurol 1999;56:1388-1393
18. Barak Y, Bodner E, Zemishilani H, et al. Donepezil for the treatment of behavioral disturbances in Alzheimer's disease: a 6 month open trial. Arch Gerontol Geriatr 2001;33:237-241
19. Wada H, Nakajoh K, Satoh-Nakagawa T, et al. Risk factors of aspiration pneumonia in Alzheimer's disease patients. Gerontology 2001;47: 271-276
20. Stolze H, Klebe S, Zechlin C, et al. Falls in frequent neurological diseases: prevalence, risk factors and etiology. J Neurol 2004;251:79-84
21. Aizawa R, Kanmayashi T, Saito Y, et al. Effects of yoku-kan-san-ka- chimpi-hange on the sleep of normal healthy adult subjects. Psychiatry Clin Neurosci 2002;56:303-304
22. Basu R, Dodge H, Stoehr GP, et al. Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition. Am J Geriatr Psychiatry 2003;11:205-213
23. Egashira N, Mishima K, Kurauchi K, et al. Cholinergic involvement in the improving effects of yoku-kan-san-ka-chimpi-hange (yi-gan-san jia-chenpi-banxia) on the disruption of spatial cognition and the electroconvulsive shock-induced immobilization. J Trad Med 2001;18:71-80
24. Yabe T, Toriizuka K, Yamada H. Effects of kampo medicines on choline acetyltransferase activity in rat embryo septal cultures. J Trad Med 1995;12:54-60
25. Ito T. Regulatory effects of yoku-kan-san-ka-chimpi-hange and saiko-ka-ryukotsu-borei-to on function of the central nervous system in mice. Prog Med 1997;17:823-830
26. Shimada Y, Goto H, Itoh T, et al. Evaluation of the protective effects of alkaloids isolated from the hooks and stems of uncaria sinensis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats. J Pharm Pharmacol 1999;51:715-722
27. Liao JF, Jan YM, Huang SY, et al. Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs. Proc Natl Sci Counc Repub China B 1995;19:151-158
28. Mizukami K, Ikonomovic MD, Grayson DR, et al. Immunohistochemical study of GABAA receptor alpha 1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Brain Res 1998;799:148-155
29. Zubenko GS, Moossy J, Martinez AJ, et al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol 1991;48:619-624